Venous Diseases
News from the FDA/CDC
FDA approves Doptelet for liver disease patients undergoing procedures
Avatrombopag (Doptelet) is the first drug approved for thrombocytopenia in adults who have chronic liver disease and are undergoing a procedure....
From the Journals
Adding vasopressin in distributive shock may cut AF risk
Adding vasopressin cut risk of atrial fibrillation, compared with catecholamine vasopressors alone.
Feature
New BP guidelines synergize with transformed primary care
The new ACC/AHA BP guidelines fit the system approach to primary care that has transformed U.S. medicine over the past decade.
Conference Coverage
Heart disease in GPA exacts high toll in year 2 and beyond
LIVERPOOL, ENGLAND - Heart disease accounts for most granulomatosis with polyangiitis deaths 1-5 years after diagnosis.
Conference Coverage
Drug-coated balloons: The future of hemodialysis access?
Patency rates with drug-coated balloons are superior to standard balloon angioplasty for stenotic AV fistulae and grafts.
From the Journals
Early endovenous ablation speeds venous ulcer healing
Treating venous ulcers early with endovenous ablation could significantly improve healing times and delay the recurrence of ulcers.
Conference Coverage
Controversy surrounds calf vein thrombosis treatment
CHICAGO – Anticoagulation, filter, or surveillance? Large retrospective study provides answers.
Conference Coverage
Late thrombectomy for stroke has low number needed to treat for benefit
LOS ANGELES – The number needed to treat varied according to the level of functional outcome achieved.
News
New hematologic, cardiovascular system link may have therapeutic implications
Early research sheds light on sex differences in thrombosis risk.
Opinion
Use of non–vitamin K antagonist oral anticoagulants in the acute care, periprocedural settings
NOACs: Handle with care because only a few have a back door.
